BD Diagnostics announced that it has received clearance from the FDA for nasopharyngeal wash, aspirate, and swab in transport media specimens on the BD Veritor System for Rapid Detection of Flu A+B.
The BD Veritor System for Rapid Detection of Flu A+B eliminates possible misinterpretations of visually read assays and helps deliver an accurate read by providing results on a hand held reader with an easy-to-read digital display. This new system has demonstrated proven performance vs. polymerase chain reaction (PCR) tests. This is the only rapid diagnostic flu test that has been referenced and FDA cleared against this high-sensitivity standard.
The BD Veritor System utilizes Advanced Particle and Adaptive Read technologies. The Advanced Particle technology helps increase the sensitivity of the test, and the Adaptive Read technology helps reduce false-positive results by examining and compensating for many of the effects of non-specific binding which improves specificity.
The BD Veritor System is currently cleared for use in clinical settings.
For more information call (800) 675-0908 or visit www.bd.com/ds/veritorsystem.